Company intelligence / Profile preview

Tree of Life Pharma Ltd.

Lod, Central District, Israeleng.treeoflife.co.il ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Tree of Life Pharma developed dozens of unique health products—mainly OTC medications and medical devices—some protected by international patents. Their products are widely distributed in Israel’s pharmacies and exported internationally. The company was acquired by Rekah Pharmaceutical in June 2021.

Therapeutic areas: OtherGastroenterologyInfectious Diseases
Modalities: Mucoadhesive formulations (e.g., gels, tablets)OTC medications and medical devicesNutritional supplements
Industry: Biotech

Drug pipeline

6 assets

Dragon Plaster

Commercial

Indications: Muscle pain

5 more assets in the full pipeline.

Request access →

Partnerships

Not specifically disclosed; some manufacturing partnerships for overseas production noted.

Beyond the preview

Go deeper on Tree of Life Pharma Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tree of Life Pharma Ltd..

Explore the full profile